PALANTIR & TELADOC STOCKS JUST CRASHED. DO THIS NOW!

TL;DR

This analysis discusses the current state of Palantir and Teledoc stocks, including their recent crashes, potential as money-maker stocks, and the importance of understanding their long-term growth stories.

Transcript

well howdy there you made it into this video where we're about to get into palantir stock and teledoc stock p l t r and t dock all right both these stocks for a lack of a better word they have crashed right both these stocks have crashed and so we in this video i want to talk about both these companies in depth okay and i want to share some thought... Read More

Key Insights

• 🍉 Palantir and Teledoc have crashed significantly, but their long-term growth potential remains promising.
• 🧡 Investors have entered Palantir between $27 and $45, while Teledoc was primarily bought in the $100 to $200 range.
• 🪐 The profitability of these stocks depends on accurate revenue and net income projections.
• 😑 Both stocks will encounter challenges, such as bad press and decelerated growth, but their long-term stories are compelling.
• 🥹 Holding growth stocks requires perseverance through downtrends and storms.
• 🍉 Palantir and Teledoc have significant long-term growth opportunities, but short-term volatility should be anticipated.
• ⌛ Palantir is considered a more popular stock, but Teledoc might have an easier time gaining public support.

Questions & Answers

Q: What is the market capitalization of Palantir and Teledoc?

After the recent crashes, Palantir has a market cap of over $30 billion, while Teledoc's market cap is over $10 billion.

Q: Why is Palantir considered a more popular stock than Teledoc?

Palantir receives more attention and views, with a higher ranking in Kathy Wood's holdings. However, Teledoc is seen as having more potential by Kathy Wood.

Q: What projections should investors run to determine the profitability of these stocks?

Investors should project revenue and net income for the next few years to assess the potential profitability of Palantir and Teledoc. If they can't accurately run these projections, it's risky to invest in these growth stocks.

Q: Are Palantir and Teledoc going through a short-term storm?

Palantir is expected to face criticism and bad press over the next years, while Teledoc might experience a substantial decrease in growth rate. Both stocks are facing challenges, but their long-term potential remains intact.

Summary & Key Takeaways

• Palantir and Teledoc stocks have experienced significant crashes, reaching new 52-week lows.

• Most investors entered Palantir stock between $27 and $45, while Teledoc stock was bought primarily in the $100 to $200 range.

• Investors in both stocks are likely underwater, but the long-term potential for profitability and growth is promising.